Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection

被引:121
作者
Levy, MT
McCaughan, GW
Marinos, G
Gorrell, MD
机构
[1] Royal Prince Alfred Hosp, Centenary Inst Canc Med & Cell Biol, AW Morrow Gastroenterol & Liver Ctr, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] Prince Wales Hosp, Dept Gastroenterol, Sydney, NSW, Australia
来源
LIVER | 2002年 / 22卷 / 02期
关键词
hepatic stellate cell; cirrhosis; hepatitis C; fibroblast activation protein; alpha smooth muscle actin; glial fibrillary acidic protein;
D O I
10.1034/j.1600-0676.2002.01503.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Activated hepatic stellate cells (HSCs), recognised by their alpha smooth muscle actin immunoreactivity, are primarily responsible for liver fibrosis. However, the presence of alpha smooth muscle actin positive HSCs is not always associated with the development of liver fibrosis. Recently, other markers of human HSCs including the gelatinase fibroblast activation protein (FA-P) and glial fibrillary acidic protein have been identified. Aims: We examined the relationship between the expression of these HSC markers and the severity of liver injury in patients with chronic hepatitis C virus infection. Methods: Liver tissue from 27 patients was examined using immunohistochemistry. Linear correlation analysis was used to compare staining scores with the stage and grade of liver injury. Results-Conclusions: FAT expression, seen at the tissue-remodelling interface, was strongly and significantly correlated with the severity of liver fibrosis. A weaker correlation was seen between glial fibrillary acidic protein expression and fibrosis stage. This contrasted with the absence of a relationship between alpha smooth muscle actin and the fibrotic score. A correlation was also observed between FAT expression and necroinflammatory score. In summary, FA-P expression identifies a HSC subpopulation at the tissue-remodelling interface that is related to the severity of liver fibrosis.
引用
收藏
页码:93 / 101
页数:9
相关论文
共 51 条
[1]   Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted β propeller domain [J].
Abbott, CA ;
McCaughan, GW ;
Levy, MT ;
Church, WB ;
Gorrell, MD .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 266 (03) :798-810
[2]   Pathogenesis of liver fibrosis [J].
Alcolado, R ;
Arthur, MJP ;
Iredale, JP .
CLINICAL SCIENCE, 1997, 92 (02) :103-112
[3]  
BROCK TO, 1987, J NEUROSCI, V7, P931
[4]   The thyroid hormone-induced tail resorption program during Xenopus laevis metamorphosis [J].
Brown, DD ;
Wang, Z ;
Furlow, JD ;
Kanamori, A ;
Schwartzman, RA ;
Remo, BF ;
Pinder, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :1924-1929
[5]   ACETALDEHYDE INCREASES PROCOLLAGEN TYPE-I AND FIBRONECTIN GENE-TRANSCRIPTION IN CULTURED RAT FAT-STORING CELLS THROUGH A PROTEIN-SYNTHESIS DEPENDENT MECHANISM [J].
CASINI, A ;
CUNNINGHAM, M ;
ROJKIND, M ;
LIEBER, CS .
HEPATOLOGY, 1991, 13 (04) :758-765
[6]   Synaptophysin: A novel marker for human and rat hepatic stellate cells [J].
Cassiman, D ;
van Pelt, J ;
De Vos, R ;
Van Lommel, F ;
Desmet, V ;
Yap, SH ;
Roskams, T .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06) :1831-1839
[7]  
CHOE I, 1987, J BIOL CHEM, V262, P5408
[8]   SYNAPTOPHYSIN GENE-EXPRESSION IN HUMAN BRAIN - A QUANTITATIVE IN-SITU HYBRIDIZATION AND IMMUNOCYTOCHEMICAL STUDY [J].
EASTWOOD, SL ;
BURNET, PWJ ;
MCDONALD, B ;
CLINTON, J ;
HARRISON, PJ .
NEUROSCIENCE, 1994, 59 (04) :881-892
[9]  
ENZAN H, 1994, VIRCHOWS ARCH, V424, P249
[10]   Molecular mechanisms of hepatic fibrosis and principles of therapy [J].
Friedman, SL .
JOURNAL OF GASTROENTEROLOGY, 1997, 32 (03) :424-430